Profile of:
Stefan Siebert
Professor of Inflammation Medicine and Rheumatology, University of Glasgow Consultant Rheumatologist
Full name: Stefan Siebert
Current country: United Kingdom
Membership level: Full
Type of membership: Member
Number of publications: 14
Comorbidity burden in axial spondyloarthritis: a cluster analysis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31220322/
Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31848736/
Treatment strategies in axial spondyloarthritis: what, when and how? (2020)
https://pubmed.ncbi.nlm.nih.gov/33053192/
The IL-23/IL-17A Axis in Spondyloarthritis: Therapeutics Informing Pathogenesis? (2020)
https://pubmed.ncbi.nlm.nih.gov/32412997/
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? (2019)
https://pubmed.ncbi.nlm.nih.gov/30297330/
Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study. (2019)
https://pubmed.ncbi.nlm.nih.gov/30647169/
AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). (2019)
https://pubmed.ncbi.nlm.nih.gov/31143851/
Non-radiographic axial spondyloarthritis (nr-axSpA) – Advances in classification, imaging and therapy. (2019)
https://pubmed.ncbi.nlm.nih.gov/30788779/
Level of adherence to prescribed exercise in spondyloarthritis and factors affecting this adherence: a systematic review. (2019)
https://pubmed.ncbi.nlm.nih.gov/30649569/
Influence of co-morbid fibromyalgia on disease activity measures and response to TNF inhibitors in axial spondyloarthritis: results from a UK national register. (2018)
https://pubmed.ncbi.nlm.nih.gov/30053166/
The co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: Results from a UK national register (BSRBR-AS). (2017)
https://pubmed.ncbi.nlm.nih.gov/28622461/
BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. (2017)
https://pubmed.ncbi.nlm.nih.gov/27558584/
Ankylosing Spondylitis Patients Display Altered Dendritic Cell and T Cell Populations That Implicate Pathogenic Roles for the IL-23 Cytokine Axis and Intestinal Inflammation. (2016)
https://pubmed.ncbi.nlm.nih.gov/26320138/
Modelling health utility values in Ankylosing Spondylitis: Comparisons of direct and indirect methods. (2015)
https://pubmed.ncbi.nlm.nih.gov/26091596/